Track the latest insights on caprolactam price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Get real-time access to monthly/quaterly/yearly prices, Request Sample
During the first quarter of 2025, the caprolactam prices in the USA reached 2025 USD/MT in March. Prices increased as energy costs rose and demand from the automotive and textile industries remained consistent. The bullish trend was further fueled by a recovery in manufacturing and improved car sales as the quarter drew to a close, despite a slight easing of raw material prices.
During the first quarter of 2025, the caprolactam prices in China reached 1375 USD/MT in March. Prices in China decreased due to oversupply and weak demand. The early softness in benzene and cyclohexanone led to lower production costs. However, the market movement slowed due to reduced procurement ahead of the Lunar New Year. Nonetheless, prices remained under pressure due to weak downstream demand for PA6 and export slowdowns.
During the first quarter of 2025, the caprolactam prices in Germany reached 1856 USD/MT in March. Prices rose slightly even though demand was limited. The production costs improved due to the skyrocketing prices of feedstock and energy. Moreover, port bottlenecks and logistical delays increased pressure, while plant closures in Central Europe diminished regional supply.
During the first quarter of 2025, the caprolactam prices in the UAE reached 1471 USD/MT in March. Prices decreased due to a continued influx of imports from China and a lack of demand from downstream consumers. The brief recovery observed in the middle of the quarter was due to increased feedstock costs and a tighter Chinese supply following the holidays.
During the first quarter of 2025, the caprolactam prices in South Korea reached 1644 USD/MT in March. The market exhibited a combination of positive and negative indicators. Limited early gains were due to low procurement ahead of the Lunar New Year and reduced export competitiveness. Phenol shortages and a tighter regional supply led to a slight mid-quarter increase. Nevertheless, demand in the automotive and textile sectors remained subdued, and surplus inventories dampened sentiment.
During the fourth quarter of 2024, the caprolactam prices in the United States reached 1850 USD/MT. The market faced weak requirement and logistical constraints in the quarter. Declines feedstock charges and hurricanes disrupted supply chains, while political issues following the presidential election caused cautious procurement. Some demand recovery in automotive was seen later, but it failed to counteract the overall downward market trend.
In the fourth quarter of 2024, caprolactam prices in China remained mostly stable with minor fluctuations. The quarter ended with caprolactam priced at 1425 USD/MT in December. The regional market struggled with oversupply and sluggish requirement from the textile and automotive industries in Q4 2024. Year-end destocking efforts and low benzene prices further pushed prices downward. Pre-holiday procurement was subdued, while a weak order pipeline and excessive inventories prevented any substantial market recovery.
During the fourth quarter of 2024, caprolactam pricing in Germany saw fluctuations. The quarter ended with caprolactam priced at 1820 USD/MT in December. The market continued its downward trend in the final quarter of 2024 due to sluggish demand from automotive and textile sectors. Lower feedstock costs failed to stabilize the market, while increased competition from Chinese electric vehicle manufacturers pressured domestic production. Regulatory changes and sustainability-driven consumer behavior further dampened market outlook.
In the fourth quarter of 2024, caprolactam prices in UAE remained mostly stable with minor fluctuations. The quarter ended with caprolactam priced at 1560 USD/MT in December. The UAE’s market saw a notable reduction in the quarter, influenced by inadequate downstream requirement and aggressive price competition from Asian exporters. Port congestion and global geopolitical concerns slowed procurement activity. Despite logistical disruptions, excess supply and hesitant purchasing behavior kept prices under pressure, leading to further discounts.
The caprolactam prices in the United States for Q3 2024 reached 1856 USD/MT in September. The relationship between fluctuations in prices and seasonal influences is clear in the country, with prices rising significantly compared to Q2. However, despite this increase, industries encountered difficulties due to hurricanes that caused disruptions in the supply chain. Additionally, a decline in demand from international markets further intensified the volatility in prices.
The price trend for caprolactam in China for Q3 2024 settled at 1727 USD/MT in September. The country experienced notable price volatility, driven by oversupplies of caprolactam, reduced requirements, and declining raw material costs. In the third quarter of 2024, the price of caprolactam declined significantly compared to Q2, reinforcing the ongoing decline. Toward the closing of Q3, prices had decreased notably, reflecting the difficult market conditions.
In Germany, the caprolactam prices for Q3 2024 reached 2100 USD/MT in September. The country witnessed a notable decrease in prices, primarily due to reduced demand from the textile sector. With consumers increasingly favoring sustainable alternatives, sales of caprolactam have been adversely affected. Toward the closing of Q3, caprolactam prices dropped significantly, indicating an overall pessimistic market sentiment.
The prices for caprolactam for Q3 in the United Arab Emirates settled at 1845 USD/MT in September. The country experienced notable price shifts, with a substantial decrease compared to Q2. Toward the closing of the quarter, caprolactam prices had fallen significantly, reflecting the pessimistic market landscape. Overall, Q3 was marked by a continued downturn, highlighting the wider challenges in the industry.
The caprolactam prices in the United Arab Emirates for Q2 2024 reached 2099 USD/MT in June. Toward the end of the quarter, caprolactam prices reflected a strong downward trend in the market. This decline highlighted a challenging market landscape, driven by surplus supplies and moderate requirements. Businesses were reluctant to invest in increasing their caprolactam supplies on account of the underperformance of the automotive and textile industries, resulting in a steady but repressed industry sentiment. Overall, Q2 was characterized by a steady downturn, with caprolactam prices continuing to face a difficult environment.
The price trend for caprolactam in South Korea for Q2 2024 settled at 3012 USD/MT in June. The country witnessed significant fluctuations in prices, with an overall pessimistic market sentiment. Seasonal factors, including reduced buying activities due to holiday seasons and a wary stance from end-use sectors in restocking inventories, have strongly influenced market dynamics. Compared to Q2 2023, there was a notable decrease in prices, reflecting the diminished requirements. In addition to this, prices fell significantly from Q1 2024, further underscoring the ongoing downward pricing trend.
The caprolactam prices in the United States for Q1 2024 reached 1719 USD/MT in March. The country witnessed a steady pricing trend, bolstered by balanced supplies. However, a minor price hike was recorded in comparison to the latter part of Q4 2023, suggesting a mild uptick in fresh orders. When compared to the same period last year, the price of caprolactam was unchanged, with no notable fluctuations.
In Germany, the caprolactam prices for Q1 2024 reached 2432 USD/MT in March. The market experienced notable fluctuations in prices during this period. Initially, the pricing environment stayed stable. Regardless of these steady prices, requirements remained weak. The lackluster need was mainly due to excess supplies, which resulted in fewer new orders.
The prices for caprolactam for Q1 in the United Arab Emirates settled at 2181 USD/MT in March. Initially, the country largely witnessed an upward pricing trend. Regardless of the rising trajectory, requirements for caprolactam in end-use industries were fairly steady. The rise in raw material costs during the first quarter of 2024 added to the issues faced by these industries. In addition to the cost increase, the industry also dealt with several interruptions, which contributed further to price hikes. This combination of disruptions and heightened demand during the period led to the upward pricing trajectory across the region.
The caprolactam prices in Germany for Q4 2023 reached 2513 USD/MT in December. The market was characterized by stable prices due to consistently low demand. The market saw a narrow pricing range as domestic orders dwindled, reflecting cautious procurement strategies among buyers. The purchasing activities in the German market declined further in October, indicating a reserved approach impacted by overall market outlook and strategic considerations among end user industries, particularly in sectors like polyamide 6.
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the caprolactam price trend.
The report offers a holistic view of the global caprolactam pricing trends in the form of caprolactam price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price levels but also provides insights into historical price of caprolactam, enabling stakeholders to understand past fluctuations and their underlying causes. The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed caprolactam demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Q1 2025:
As per the caprolactam price index, prices in Europe increased. Production costs were driven up by higher prices for crude-linked feedstock and energy, while strikes and labor shortages caused delivery disruptions at critical ports. During the middle of the quarter, supply pressure ramped up due to shutdowns at BASF's site in Ludwigshafen and a production facility in the Czech Republic. These outages reduced local production, even as downstream industries were cautious due to high inflation and weak consumer confidence.
Q4 2024:
In Q4 2024, the market in Europe continued to see price drops given the decreased demand for textiles and automobiles. The demand for caprolactam-based components decreased as a result of local production being hampered by competition from Chinese EV producers. Consumption of textiles was further limited by customer preferences motivated by sustainability. Market stability remained elusive in spite of stable manufacturing and decreasing feedstock charges. Temporary respite was provided by a modest drop in logistical charges, but future EU regulatory changes are anticipated to raise operating expenses. The market remained under pressure with few indications of improvement due to seasonal considerations such as stock management and sluggish year-end demand.
Q3 2024:
Throughout the third quarter of 2024, the price of caprolactam in Europe witnessed a notable downturn, mainly due to reduced requirements from end-use sectors. Several circumstances influenced this downturn, including a slowdown in the textile and automotive industries, diminished production output, and a lack of fresh orders. The market also faced challenges such as rising transportation expenses, operational interruptions, and delivery uncertainties. Overall, the third quarter of 2024 was marked by pessimistic market sentiment, with low requirements and difficult supply conditions undermining stable pricing across the European market.
Q2 2024:
In Q2 2024, caprolactam prices in Europe remained stable, driven by balanced supply-demand dynamics. Although production volumes were moderate and inventory levels were adequate, requirements from end-use industries, automotive and textiles, in particular, stayed weak. Elevated rates of interest and ongoing international pressures contributed to cautious buying behavior, leading to low activity in the market. This ongoing reluctance from both businesses and consumers prevented notable changes in caprolactam prices throughout the quarter.
Q1 2024:
Throughout Q1 2024, caprolactam experienced mixed pricing patterns in Europe. As the period advanced, prices saw a significant rise. Additionally, continuous interruptions in shipping lines negatively affected raw material inventories, intensifying the market conditions. These supply network issues had a ripple effect on end-use industries, leading to volatility in prices. Consequently, manufacturers raised prices, seeking to improve profits after an extended duration of limited price movement.
Q4 2023:
The European caprolactam market showed a bearish trend in the fourth quarter of 2023, characterized by ample supply and subdued demand. The prevalent supply abundance prompted a conservative buying approach from downstream industries, impacting the market negatively. Furthermore, increased cost pressures due to imported cargoes affected market dynamics. In Germany, caprolactam prices remained consistently low due to limited domestic orders, reflecting a cautious purchasing pattern. Downstream sectors, particularly polyamide 6 producers, purchased conservatively, indicating a strategic shift to more reserved market engagement under the prevailing economic conditions.
This analysis can be extended to include detailed caprolactam price information for a comprehensive list of countries.
Region | Countries Covered |
---|---|
Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
Q1 2025:
Caprolactam prices rose due to positive momentum in energy markets and strong demand from the automotive and textile industries. The rise in benzene feedstock prices and production costs was fueled by increased inflation expectations. After Winter Storm Enzo, labor stability resulting from a new accord among major unions contributed to the normalization of port operations. After the announcement of tariffs on goods from Canada and Mexico, speculative purchasing surged as importers aimed to lock in lower-cost materials.
Q4 2024:
The market experienced a slight downturn in the final quarter of 2024, influenced by weak downstream demand, supply network issues, and fluctuating feedstock costs. The beginning of the quarter saw sluggish activity in key sectors such as automotive and textiles, exacerbated by decreased benzene prices that pressured suppliers to maintain volume over profitability. Additionally, severe weather disruptions, such as hurricanes, created logistical constraints that further unsettled the market. Political issues following the U.S. presidential election contributed to a cautious approach from buyers, leading to inventory accumulation and extended delivery times. While there was some revival in requirement towards the quarter’s end, especially from the automotive industry, it was insufficient to counteract the earlier downturn. Concerns over new trade policies under the incoming administration encouraged some forward buying, but overall market sentiment remained subdued.
Q3 2024:
In Q3 2024, prices of caprolactam in North America experienced a notable rise. This price increase is due to a combination of factors. Despite a decrease in demand from end-use sectors due to a downturn in the textile industry and instability in the automobile sector, supply conditions have been heavily impacted by recent hurricanes, which are driving the pressure on prices. Overall, these disruptions have caused substantial issues in supply networks, contributing to the upward pricing trend.
Q2 2024:
During the second quarter of 2024, prices of caprolactam in North America remained stable to moderately weak, largely due to low demand from end-use industries, such as textiles and automotive. With excess supplies and wary purchasing behavior, manufacturers saw a decline in orders, leading to continued reductions in prices. The sluggish performance of the international textile market, worsened by global pressures and rising rates of interest, further suppressed the need for caprolactam. Additionally, logistical constraints, such as restricted container capacity and increased transportation costs, limited international demand, putting further pressure on prices.
Q1 2024:
In the first quarter of 2024, prices of caprolactam in North America were shaped by several factors. Ongoing disruptions in supply networks contributed to price fluctuations, while changes in feedstock costs added to market instability. Additionally, weak requirements from end-use industries continued, intensifying the volatile pricing environment. Overall, the interplay of supply chain dynamics, feedstock price fluctuations, and requirements from end-use industries significantly influenced the prices of caprolactam in the North American market.
Q4 2023:
In the fourth quarter of 2023, the North American caprolactam market experienced a downturn, largely due to diminished trading activities. A significant oversupply in the market coupled with reduced purchasing led to a bearish outlook. The decline in caprolactam demand was further exacerbated by uncertainties in economic outlook that prompted customers to minimize their inventory levels. Additionally, fluctuating prices of raw materials, especially benzene, impacted caprolactam pricing negatively. Despite the year-end sales pushing some destocking, expectations of an uptick in domestic purchasing activities remained modest, keeping the market conditions predominantly bearish with a stable supply but weak demand.
Specific caprolactam historical data within the United States and Canada can also be provided.
Region | Countries Covered |
---|---|
North America | United States and Canada |
Q1 2025:
As per the caprolactam price chart, the market experienced a price decline due to weak consumption trends outweighing the effects of stable supply. Tepid orders from the auto and textile sectors, along with global oversupply, contributed to early softness. Prices experienced a brief rebound in the middle of the quarter, driven by a tightening of Chinese supply after the holidays and increases in feedstock costs, along with some inventory replenishment in automotive chains.
Q4 2024:
The Middle East and Africa market witnessed a sharp decline in Q4 2024 due to weak demand and competitive pricing from Asian exporters. Limited procurement activity mirrored trends in key exporting nations, driving price corrections. Geopolitical concerns and port jams further dampened purchasing sentiment, while low cargo requirement lowered transportation charges. Despite logistical disruptions from storms, supply remained ample, preventing any price recovery. Abundant inventories and sluggish demand led manufacturers to offer discounts to clear stocks, reinforcing the bearish trend that persisted throughout the quarter with no significant signs of improvement.
Q3 2024:
During the third quarter of 2024, prices of caprolactam in Middle East and Africa witnessed a substantial drop, driven by numerous contributing influences. The surplus supply of caprolactam from international distributors resulted in weaker demand, creating a declining pricing trajectory. Moreover, persistently low order volumes from end-use industries, particularly textiles and automotive, intensified the downward trend. The steady supply network and sufficient raw material availability also played a role in reinforcing the downturn in prices.
Q2 2024:
In Q2 2024, the price of caprolactam in Middle East and Africa experienced a significant decrease, largely due to weak requirements from end-use sectors. A subdued international economy, along with operational interruptions and fluctuations in the cost of raw materials, further restrained market activities. The industry environment was shaped by careful inventory replenishment, as companies chose to keep stock levels low amid demand uncertainties. The steady supply of caprolactam and moderate international prices also contributed to the declining pricing trend.
Q1 2024:
Throughout Q1 2024, caprolactam prices in Middle East and Africa witnessed a significant rise, largely due to increasing costs in exporting nations. Disruptions in cargo imports, caused by the Red Sea conflict, had a notable impact on business operations. These interruptions intensified the pressures on prices and led to substantial setbacks in deliveries. Businesses experienced some of the worst distributor performance in the past year, further complicating the challenging industry environment.
Q4 2023:
The report explores the caprolactam pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on caprolactam prices for countries can also be provided.
Region | Countries Covered |
---|---|
Middle East and Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Q1 2025:
In the first quarter of 2025, the market exhibited a downward trend due to ongoing oversupply and cautious demand. The prices of benzene and cyclohexanone showed early-quarter softness, which led to a decrease in production costs. However, the momentum was constrained by weak procurement from the automotive and textile sectors. The Lunar New Year holidays contributed to the lull and there was a temporary price increase due to phenol supply constraints following plant closures.
Q4 2024:
In the fourth quarter of 2024, the region's caprolactam market was under pressure to decline attributed to excess and poor demand from important industries. Typhoon-related shipping difficulties replaced the initial steadiness, resulting in brief delays. Manufacturers engaged in aggressive year-end destocking as the quarter went on, despite weak demand in the automotive and textile industries. Price reductions were caused by low benzene costs and rising stocks. A difficult picture with ongoing pricing pressure and few chances for recovery was ensured by seasonal considerations, including pre-holiday purchases prior to Chinese New Year, which further slowed market activity.
Q3 2024:
During the third quarter of 2024, caprolactam prices in Asia Pacific continued to decline, driven mainly by sluggish demand from end-use industries such as automotive and textiles. Seasonal trends and diminished consumer expenditure further weakened demand, leading to limited purchasing activity. Additionally, the international textile sector is gradually reducing the use of synthetic fibers due to growing concerns about sustainability, which has worsened the volumes of surplus inventory. The low requirements, changing market sentiments, and excess supply have intensified the difficult pricing environment for caprolactam in Asia Pacific.
Q2 2024:
Q2 2024 experienced a considerable decline in prices of caprolactam throughout Asia Pacific. This downturn was mainly driven by ongoing reduced need from end-use sectors such as automotive and textiles, along with abundant inventories and stable raw material costs. Additionally, international pressures and reduced exports further worsened the subdued industry environment. Overall, the market sentiment has remained pessimistic, highlighting the continual struggles of the market with excess supplies and low requirements.
Q1 2024:
In Q1 2024, caprolactam prices in Asia Pacific followed varying patterns. The increase in raw material prices had a notable impact on the caprolactam industry. Despite a slight uptick in the market landscape environment during Q4 2023, the overall situation stayed difficult by Q1 2024, reflecting the ongoing challenges faced by businesses. The primary concern remained reduced requirements, which overshadowed the modest gains in order levels and volume utilization.
Q4 2023:
During the last quarter of 2023, the caprolactam market in the Asia Pacific region was marked by an excess supply and a contraction in demand. This situation arose from multiple factors including decreased production and subdued demand from customers. A notable decrease in the price of benzene significantly impacted the cost structure, weakening the market's financial support. Additionally, the demand from end use sectors like electronics and textiles softened, further dampening the market dynamics. Despite a slight recovery in production and a slowdown in the decline of new export orders by December, the overall market remained cautious, with limited international inquiries as the year concluded.
This caprolactam price analysis can be expanded to include a comprehensive list of countries within the region.
Region | Countries Covered |
---|---|
Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Q1 2025:
Latin America's caprolactam market is predominantly influenced by its rich natural reserves, particularly in countries like Chile and Brazil. However, political instability and inconsistent regulatory frameworks can lead to significant volatility in caprolactam prices. Infrastructure challenges and logistical inefficiencies often impact the supply chain, affecting the region's ability to meet international demand consistently. Moreover, the caprolactam price index, economic fluctuations, and currency devaluation are critical factors that need to be considered when analyzing caprolactam pricing trends in this region.
Q4 2024:
The analysis of caprolactam prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region | Countries Covered |
---|---|
Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
IMARC's latest publication, “Caprolactam Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the caprolactam market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of caprolactam at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents a detailed caprolactam price trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting caprolactam pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
The global caprolactam market size reached USD 17.47 Billion in 2024. By 2033, IMARC Group expects the market to reach USD 24.87 Billion, at a projected CAGR of 3.80% during 2025-2033.
The report covers the latest developments, updates, and trends impacting the global caprolactam industry, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in caprolactam production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the caprolactam price trend.
Latest developments in the caprolactam industry:
Caprolactam is a white, crystalline solid chemical compound that dissolves in water and has a distinct smell. It is made by rearranging functional groups in cyclohexanone oxime via the Beckmann rearrangement, which is done under carefully monitored settings.
It is utilized in the ring-opening polymerization process, which creates strong and adaptable polymer chains using heat and catalysts to produce Nylon 6. It has high tensile strength, flexibility, chemical resistance, and durability, making it suitable for a broad spectrum of applications. It is used in the creation of several pharmaceutical drugs, including pentylenetetrazol, meptazinol, and laurocapram. It is also utilized in the production of lysine, brush bristles, synthetic leather, paint vehicles, plasticizers, brush bristles, and polyurethane cross-linking.
In addition, caprolactam-derived nylon resins find applications in the manufacture of high-performance technical polymers, which are used in consumer goods, mechanical parts, and electronic components.
Key Attributes | Details |
---|---|
Product Name | Caprolactam |
Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Caprolactam Price Analysis, and Segment-Wise Assessment. |
Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
|
Customization Scope | The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
Post-Sale Analyst Support | 360-degree analyst support after report delivery |
Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders: